From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D plus all-trans retinoic acid plus Temozolomide combination in treatment of GBM

Ilhan Elmaci, Aysel Ozpinar, Alp Ozpinar, Jennifer L. Perez, Meric A. Altinoz*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)687-704
Number of pages18
JournalMetabolic Brain Disease
Volume34
Issue number3
DOIs
Publication statusPublished - Jun 2019

Keywords

  • Glioblastoma
  • Glioma
  • Vitamin D
  • Vitamin a
  • Temozolomide
  • NERVE GROWTH-FACTOR
  • NEUROTROPHIC FACTOR GDNF
  • D-RECEPTOR EXPRESSION
  • 1,25-DIHYDROXYVITAMIN D-3
  • BRAIN-TUMOR
  • CELL-DEATH
  • C6 GLIOMA
  • PHASE-II
  • MEDROXYPROGESTERONE ACETATE
  • CANCER

Cite this